Evidence map›Paper›PMID 36835108›Full record

ReviewInternational journal of molecular sciences2023

Tear Film MicroRNAs as Potential Biomarkers: A Review.

Jeremy Altman, Garrett Jones, Saleh Ahmed, Shruti Sharma, Ashok Sharma

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Tear fluid database: a reference website for tear fluid proteomics.Database : the journal of biological databases and curation · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. A Review of the Tear Film Biomarkers Used to Diagnose Sjogren's Syndrome.International journal of molecular sciences · 2024
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Tear Biomarkers and Alzheimer's Disease.International journal of molecular sciences · 2023
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jeremy AltmanCenter for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Garrett JonesCenter for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Saleh AhmedCenter for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Shruti SharmaCenter for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Ashok SharmaCenter for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.ORCID 0000-0001-9597-4374
Augusta University · US

Funding

Module 3: Gene Expression/ProteomicsP30EY031631 · NEI · AUGUSTA UNIVERSITY · PI Xingjun Fan · 2020 to 2026
$3.6M
Targeting Interleukin-6 Trans-signaling in Diabetic RetinopathyR01EY026936 · NEI · AUGUSTA UNIVERSITY · PI SHARMA, SHRUTI · 2016 to 2019
$1.5M
Proteomic Biomarkers for Glaucomatous Optic NeuropathyR01EY029728 · NEI · AUGUSTA UNIVERSITY · PI SHARMA, ASHOK · 2019 to 2022
$1.5M
NEI NIH HHS P30 EY031631NEI NIH HHS R01 EY026936NEI NIH HHS R01-EY026936; R01-EY029728; P30 EY031631NEI NIH HHS R01 EY029728
6 · The paper itself

Abstract

MicroRNAs are non-coding RNAs that serve as regulatory molecules in a variety of pathways such as inflammation, metabolism, homeostasis, cell machinery, and development. With the progression of sequencing methods and modern bioinformatics tools, novel roles of microRNAs in regulatory mechanisms and pathophysiological states continue to expand. Advances in detection methods have further enabled larger adoption of studies utilizing minimal sample volumes, allowing the analysis of microRNAs in low-volume biofluids, such as the aqueous humor and tear fluid. The reported abundance of extracellular microRNAs in these biofluids has prompted studies to explore their biomarker potential. This review compiles the current literature reporting microRNAs in human tear fluid and their association with ocular diseases including dry eye disease, Sjögren's syndrome, keratitis, vernal keratoconjunctivitis, glaucoma, diabetic macular edema, and diabetic retinopathy, as well as non-ocular diseases, including Alzheimer's and breast cancer. We also summarize the known roles of these microRNAs and shed light on the future progression of this field.

Indexed as

Diabetic RetinopathyMacular EdemaMicroRNAsSjogren's SyndromeBiomarkersHumansTearsBiomarkersMicroRNAsAlzheimer’s and breast cancerbiomarkermicroRNAocular diseasestear film

Identifiers

PMID36835108
PMCPMC9962948
OpenAlexW4320492975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.